Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ARMO Biosciences
Scientific Title
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Meta Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen